StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) income statement

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/306% below fair value
$13.55−0.31 (-2.24%)

Close on Nov 19, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences Holdings Corp income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
52.4%
Operating margin
4.4%
Net margin
0.8%
Return on equity, FY2025
-39.9%

Financial strength

Current ratio
3.62
Debt to equity
–
Debt to assets
–
Cash to current liabilities
76.7%

Valuation

P/E ratio
79.7
Price to sales
0.64
Price to book
0.99
Dividend yield
–

See a number that looks wrong?